Results

Total Results: 2,142 records

Showing results for "responses".

701. Data-Points-6-Tables (xls file)
     effectivehealthcare.ahrq.gov/sites/default/files/data-points-6-tables.xls
     January 01, 2006 - 1 Number of Beneficiaries With at Least One Part A, B, or D Drug Claim for a Biologic of Interest (among continuously enrolled AB FFS population) by Class of Drug and Active Ingredient, 2006-2009 Note: A single period (.) signifies a small cell count (less than 11). Use filters to rank by beneficiary count. …

702. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/cancer-anemia-update_research-protocol.pdf
     June 16, 2010 - A summary of relevant comments and our responses follow each key question; general comments applying … to all key questions and responses are listed after the last key question. … events including those related to red blood cell transfusion Intermediate outcomes: • hematologic responses

703. C- Evidence-based Practice Center Technical Brief Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/musculoskeletal-disorders-imaging_research-protocol.pdf
     August 05, 2010 - Each Key Informant will be individually interviewed for their responses to Key Questions 1, 2 and 4. … Key Informant responses to specific topics may be included by direct quote from recorded interviews

704. McCullough (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/mccullough.pdf
     January 01, 2011 - management: clinical ethical tool for responsibly managing uncertainty about plan of care o Candor-­‐based responses

705. Disposition of Comments for Comparative Effectiveness of Therapies for Clinically Localized Prostate Cancer: An Update of a 2008 Systematic Review (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/prostate-cancer-therapies-update_disposition-comments.pdf
     December 16, 2014 - Comments on draft reviews and the authors’ responses to the comments are posted for public viewing on … The tables below include the responses by the authors of the review to each comment that was submitted … The responses to comments in this disposition report are those of the authors, who are responsible for

706. Microsoft Word - 3-DKE274__ACEI-ARB-DRI__Comments_Disposition_Table-21_Jan_2011 cyk _2_.docx (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/ace-inhibitor-arb-update_disposition-comments.pdf
     October 07, 2011 - Comments on draft reviews and the authors’ responses to the comments are posted for public viewing on … The tables below include the responses by the authors of the review to each comment that was submitted … The responses to comments in this disposition report are those of the authors, who are responsible for

707. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/preterm-birth-terbutaline-pump_disposition-comments.pdf
     September 01, 2011 - Comments on draft reviews and the authors’ responses to the comments are posted for public viewing … The tables below include the responses by the authors of the review to each comment that was submitted … The responses to comments in this disposition report are those of the authors, who are responsible

708. Development of a Primary Care Guie for Implementing Evidence-Based Screening and Counseling for Unhealthy Alcohol Use With Epic-Based Electronic Health Record Tools: A Pilot Dissemination Project (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-research-report-unhealthy-alcohol-use-final.pdf
     September 01, 2018 - Ratings of the package sections’ usefulness are summarized in Table 2, and responses to free-text questions … Responses included: • Strong evidence base • Confidence in the practice that implementation won’t … These responses suggest that information with a direct and practical application to the topic of alcohol … These responses suggest that end users may want a concise document with a “just tell me what to do”

709. Colon-Cancer-Gene-Profiling Research-Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/colon-cancer-gene-profiling_research-protocol.pdf
     March 13, 2012 - and evaluated as an indicator of normal biologic processes, pathogenic processes, or pharmacologic responses

710. The Role of Immunotherapy and the Management of Asthma: Systematic Review | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/asthma-immunotherapy/research-protocol
     September 14, 2016 - Distinct modulation of allergic T cell responses by subcutaneous vs. sublingual allergen-specific immunotherapy … The overall AQLQ score is the mean of all 32 responses and the individual domain scores are the means

711. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/breast-cancer-medications_disposition-comments.pdf
     March 10, 2010 - Comments on draft reviews and the authors’ responses to the comments will be posted publicly on the

712. Comparative Effectiveness of Second Generation Antidepressants in the Pharmacologic Treatment of Adult Depression – An Update to a 2007 Report | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/antidepressants-update/research-protocol
     July 13, 2011 - Current Page Topic Timeline Jul. 14, 2010 Topic Initiated Jul. 13, 2011 Research Protocol Dec. 5, 2011 Systematic Review May. 16, 2012 Disposition of Comments Report Comparative Effectiveness of Second Generation Antidepressants in the Pharmacologic Treatment of Adult Depression – An Update to a 2007 Report Researc…

713. Arthritis and Nontraumatic Joint Disease (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/arthritis-horizon-scan-high-impact-1506.pdf
     June 01, 2015 - significant improvement in American College of Rheumatology criteria for 20% improvement (ACR20) responses … 66.3%, and 32.6%, and patients whose symptoms did not respond to previous TNF treatment had ASAS20 responses … patients who received secukinumab 75 mg did not have significant improvements in ASAS20 or ASAS40 responses … Using an observed analysis, patients treated with secukinumab 75 mg had ACR 20/50/70 responses of 66.9%

714. Delilberative-Methods-Design-Carman (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/delilberative-methods-design-carman.pdf
     June 01, 2012 - Slide 30 Deliberative Methods Experiment Agency for Healthcare Research and Quality Community Forum Slide 31 Background & objectives of experiment  Background o Started in August 2010 o Literature review, Technical Expert Panel, formative research to inform approach  Objectives o Expand the …

715. Community Forum Deliberative Methods Demonstration: Evaluating Effectiveness and Eliciting Public Views on Use of Evidence | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/deliberative-methods/research-2013-1
     November 01, 2013 - surveys or focus groups, which generally obtain more top-of-mind--that is, initial and more intuitive--responses … Finally, responses to the question would elicit the public’s values around whether patients and physicians … The panelists’ responses were played back to participants during the third session and served as a basis … When presented with the deliberative question, many participants’ initial responses showed that they

716. The purpose of our tool is to compile a comprehensive list of questions that may be used to evaluate the quality of non-randomized studies of interventions or exposures (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/reliability-testing-grading-evidence_research.pdf
     May 01, 2012 - completed each of the exercises; subsequently, each pair of reviewers reconciled their independent responses … the 10 exercises; subsequently, the two reviewers—i.e., the ―pair‖—reconciled their independent responses … We assigned a numeric value to each of the domains/strength of evidence responses for each reviewer … Agreement improved to fair (AC1=0.22) among pairs of reviewers for the reconciled responses. … Reconciliation Across Reviewer Pairs We received responses from 8 of the 11 pairs describing the approach

717. Hit-Patient-Care Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/hit-patient-care_executive.pdf
     June 01, 2012 - Evidence-Based Practice Evidence-based Practice Program The Agency for Healthcare Research and Quality (AHRQ), through its Evidence- based Practice Centers (EPCs), sponsors the development of evidence reports and technology assessments to assist public- and private-sector organizations in their efforts to imp…

718. Disposition of Comments for CERs 155 156 Contast-Induced Nephropathy (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/nephropathy-contrast-induced_disposition-comments.pdf
     January 07, 2016 - Comments on draft reviews and the authors’ responses to the comments are posted for public viewing on … The tables below include the responses by the authors of the review to each comment that was submitted … The responses to comments in this disposition report are those of the authors, who are responsible for

719. Community Forum Deliberative Methods Demonstration: Evaluating Effectiveness and Eliciting Public Views on Use of Evidence--Executive Summary (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/deliberative-methods-demonstration-executive-131125.pdf
     November 01, 2013 - surveys or focus groups, which generally obtain more top-of-mind—that is, initial and more intuitive—responses … Finally, responses to the question would elicit the public’s values around whether patients and physicians … The panelists’ responses were played back to participants during the third session and served as a basis … • When presented with the deliberative question, many participants’ initial responses showed that

720. Cancer-Drugs-Utilization-Cost Research (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/cancer-drugs-utilization-cost_research.pdf
     January 01, 2011 - Utilization and cost of anticancer biologic products among Medicare beneficiaries, 2006-2009 Data Points #6Anticancer Biologics From 2006 to 2009, over 800,000 Medicare fee-for-service beneficiaries continuously enrolled in Parts A and B had a claim for an anticancer biologic of interest. Bevacizumab was the m…